Autores

Aniket S. Rali, Christopher Howard, Rachel Miller, Christopher K. Morgan, Dennis Mejia, John Sabo, James P. Herlihy, Sunjay R. Devarajan


Publicação: Can J Respir Ther Vol 56, p. 32-34
Ano: 23 de julho de 2020
DOI: https://doi.org/10.29390/cjrt-2020-019


Download

https://doi.org/10.29390/cjrt-2020-019

Abstract:

Noninvasive positive pressure ventilation (NIPPV) plays an important role in the management of respiratory failure. However, since the emergence of the COVID-19 pandemic, utilization of traditional face mask NIPPV has been curtailed in part due to risk of aerosolization of respiratory particles and subsequent health care worker exposure. A randomized clinical trial in 2016 reported that an alternative interface, helmet NIPPV, may be more effective than traditional NIPPV at preventing intubation and improving mortality. The helmet NIPPV interface provides positive airway pressure, while also theoretically minimizing aerosolization, making it a feasible modality in management of respiratory failure in COVID-19 patients.